Pharmacokinetics, pharmacodynamics and clinical efficacy of pertuzumab in breast cancer therapy.

about

Adjuvant trastuzumab: a 10-year overview of its benefit.

P2860

Q39018742-E27D471A-C302-47AC-9684-A85958731A10

P2860

Pharmacokinetics, pharmacodynamics and clinical efficacy of pertuzumab in breast cancer therapy.

Item

http://www.wikidata.org/entity/Q38573858

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Pharmacokinetics, pharmacodyna ...... umab in breast cancer therapy.

@en

type

Item

label

Pharmacokinetics, pharmacodyna ...... umab in breast cancer therapy.

@en

prefLabel

Pharmacokinetics, pharmacodyna ...... umab in breast cancer therapy.

@en

P1476

Pharmacokinetics, pharmacodyna ...... umab in breast cancer therapy.

@en

P2093

Alessio Schirone

http://www.w3.org/2001/XMLSchema#string

Andrea Rocca

http://www.w3.org/2001/XMLSchema#string

Anna Fedeli

http://www.w3.org/2001/XMLSchema#string

Dino Amadori

http://www.w3.org/2001/XMLSchema#string

Elisabetta Pietri

http://www.w3.org/2001/XMLSchema#string

Lorenzo Cecconetto

http://www.w3.org/2001/XMLSchema#string

Patrizia Serra

http://www.w3.org/2001/XMLSchema#string

Roberta Maltoni

http://www.w3.org/2001/XMLSchema#string

Samanta Sarti

http://www.w3.org/2001/XMLSchema#string

P2860

An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor

Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor alpha

Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains

Mechanism for activation of the EGF receptor catalytic domain by the juxtamembrane segment

Ligand-independent HER2/HER3/PI3K complex is disrupted by trastuzumab and is effectively inhibited by the PI3K inhibitor GDC-0941

ErbB3/HER3 intracellular domain is competent to bind ATP and catalyze autophosphorylation

Comprehensive molecular portraits of human breast tumours

Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab

The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors

The Juxtamembrane Region of the EGF Receptor Functions as an Activation Domain

P304

1647-1663

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/17425255.2015.1078311

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sara Bravaccini

A Farolfi

Daniele Andreis

P577

2015-08-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26307328

http://www.w3.org/2001/XMLSchema#string

Pharmacokinetics, pharmacodynamics and clinical efficacy of pertuzumab in breast cancer therapy.

about

P2860

P2860

Pharmacokinetics, pharmacodynamics and clinical efficacy of pertuzumab in breast cancer therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698